Colon cancer prevalence and estimation of differing care needs of colon cancer patients

被引:19
作者
Gatta, G
Capocaccia, R
Berrino, F
Ruzza, MR
Contiero, P
机构
[1] Ist Nazl Studio & Cura Tumori, Epidemiol Unit, I-20133 Milan, Italy
[2] Ist Super Sanita, Epidemiol & Biostat Lab, I-00161 Rome, Italy
[3] Ist Nazl Studio & Cura Tumori, Canc Registry Unit, I-20133 Milan, Italy
关键词
care prevalence; colon cancer; Europe; population-based cancer registries;
D O I
10.1093/annonc/mdh234
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Cancer prevalence-the proportion of people in a population with a diagnosis of cancer-includes groups with widely differing cancer care needs. We estimated the proportions of the prevalent colon cancer cases requiring initial care, terminal care and follow-up. Patients and methods: Prevalence by year since diagnosis was estimated from incidence and vital status data on 243 471 colon cancer cases collected by EUROPREVAL from 36 European population-based cancer registries. The proportions of cured and fatal cases were estimated by applying 'cure' survival models to the dataset. The proportion of recurrence-free cases was estimated by analysis of a representative sample of 278 colon cancer patients from the Lombardy Cancer Registry (LCR), northern Italy. Results: The proportions of total prevalence requiring initial care was estimated at 12% in the LCR and 10% in Italy and Europe. Recurrence-free patients formed 89% of the total prevalence in the LCR and 91% in Italy and Europe. Eleven per cent (LCR) and 9% (Italy, Europe) of the total prevalence had recurred and consisted of patients in the terminal phase of their illness. Conclusions: In 1992, 660000 people were living with a diagnosis of colon cancer in Europe. We have estimated the proportions of this prevalence requiring particular types health care in the years following diagnosis, providing data useful for planning the allocation of health-care resources.
引用
收藏
页码:1136 / 1142
页数:7
相关论文
共 21 条
[1]   Colorectal cancer prevalence in France [J].
Benhamiche-Bouvier, AM ;
Clinard, F ;
Phelip, JM ;
Rassiat, E ;
Faivre, J .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2000, 9 (05) :303-307
[2]   The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies [J].
Berrino, F. .
ANNALS OF ONCOLOGY, 2003, 14 :V9-V13
[3]   Cancer prevalence. What for? [J].
Berrino, F ;
Cascinelli, N .
TUMORI, 1999, 85 (05) :414-417
[4]   Measuring cancer prevalence in europe: the EUROPREVAL project [J].
Capocaccia, R ;
Colonna, M ;
Corazziari, I ;
De Angelis, R ;
Francisci, S ;
Micheli, A ;
Mugno, E .
ANNALS OF ONCOLOGY, 2002, 13 (06) :831-839
[5]  
Capocaccia R, 1997, STAT MED, V16, P425, DOI 10.1002/(SICI)1097-0258(19970228)16:4<425::AID-SIM414>3.0.CO
[6]  
2-Z
[7]   Estimation of colorectal cancer prevalence in France [J].
Colonna, M ;
Grosclaude, P ;
Launoy, G ;
Tretarre, B ;
Arveux, P ;
Raverdy, N ;
Benhamiche, AM ;
Herbert, C ;
Faivre, J .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (01) :93-+
[8]  
CROSIGNANI P, 1997, IARC SCI PUBL, V143, P566
[9]   INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL [J].
DELTURCO, MR ;
PALLI, D ;
CARIDDI, A ;
CIATTO, S ;
PACINI, P ;
DISTANTE, V ;
AZZINI, V ;
BELSANTI, V ;
BARTOLUCCI, R ;
DICOSTANZO, F ;
BERTUSI, M ;
DANESE, S ;
GIARDINA, G ;
DAIUTO, G ;
UCCELLO, V ;
DELEO, G ;
PUNZO, C ;
GOSSO, P ;
GRISO, C ;
LOCATELLI, E ;
MANSUTTI, M ;
SANDRI, P ;
MOLINO, AM ;
SCHINCAGLIA, P ;
TIENGHI, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (20) :1593-1597
[10]  
GALANDIUK S, 1992, SURG GYNECOL OBSTET, V174, P27